322 related articles for article (PubMed ID: 35632430)
21. Case Report: Omicron BA.2 Subvariant of SARS-CoV-2 Outcompetes BA.1 in Two Co-infection Cases.
Gjorgjievska M; Mehandziska S; Stajkovska A; Pecioska-Dokuzovska S; Dimovska A; Durmish I; Ismail S; Pavlovska T; Stojchevska A; Amedi H; Andonova J; Nikolovska M; Velickovikj S; Mitrev Z; Kungulovski I; Kungulovski G
Front Genet; 2022; 13():892682. PubMed ID: 35495156
[TBL] [Abstract][Full Text] [Related]
22. Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.
La Rosa G; Brandtner D; Bonanno Ferraro G; Veneri C; Mancini P; Iaconelli M; Lucentini L; Del Giudice C; Orlandi L; ; Suffredini E
Sci Total Environ; 2023 May; 873():162339. PubMed ID: 36813191
[TBL] [Abstract][Full Text] [Related]
23. Risk evaluation and mitigation strategies for newly detected SARS-CoV-2 Omicron BF.7 subvariant: A brief report.
Nazmunnahar ; Ahmed I; Islam MR
Health Sci Rep; 2023 Mar; 6(3):e1127. PubMed ID: 36875932
[TBL] [Abstract][Full Text] [Related]
24. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
[TBL] [Abstract][Full Text] [Related]
25. Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.
Osterman A; Badell I; Dächert C; Schneider N; Kaufmann AY; Öztan GN; Huber M; Späth PM; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Czibere L; Durner J; Kaderali L; Baldauf HM; Keppler OT
Med Microbiol Immunol; 2023 Feb; 212(1):13-23. PubMed ID: 36370197
[TBL] [Abstract][Full Text] [Related]
26. Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sublineage.
Mak GCK; Lau SSY; Wong KKY; Lau CS; Ng KHL; Lam ETK; Chan RCW
J Med Virol; 2022 Oct; 94(10):5033-5037. PubMed ID: 35656593
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant.
Karyakarte RP; Das R; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Rajmane MV; Kulkarni PP; Nizarudeen S; Joshi S; Potdar V; Karmodiya K
Cureus; 2023 Feb; 15(2):e35261. PubMed ID: 36968876
[TBL] [Abstract][Full Text] [Related]
28. Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study.
Li J; Zhang Q; Xu C; Zhang Y; Lu Y; Ai M; Tan X
BMC Gastroenterol; 2023 Aug; 23(1):271. PubMed ID: 37553605
[TBL] [Abstract][Full Text] [Related]
29. Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/Iraq.
Majed SO; Jalal PJ; Fatah MH; Karim KK; Karim AY; Miasko M; Hasannajad S; Mustafa SA
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):56-63. PubMed ID: 38015540
[TBL] [Abstract][Full Text] [Related]
30. First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco.
Colson P; Lavagna C; Delerce J; Groshenry G; Yahi N; Fantini J; La Scola B; Althaus T
Microorganisms; 2022 Sep; 10(10):. PubMed ID: 36296228
[TBL] [Abstract][Full Text] [Related]
31. Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India.
Zaman K; Shete AM; Mishra SK; Kumar A; Reddy MM; Sahay RR; Yadav S; Majumdar T; Pandey AK; Dwivedi GR; Deval H; Singh R; Behera SP; Kumar N; Patil S; Kumar A; Dudhmal M; Joshi Y; Shukla A; Gawande P; Kavathekar A; Kumar N; Kumar V; Kumar K; Singh RS; Kumar M; Tiwari S; Verma A; Yadav PD; Kant R
Front Med (Lausanne); 2022; 9():955930. PubMed ID: 36405589
[TBL] [Abstract][Full Text] [Related]
32. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B
Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of previous infection and vaccination against reinfection with BA.5 Omicron subvariant: a nationwide population-based study in Japan.
Kitamura N; Otani K; Kinoshita R; Yan F; Takizawa Y; Fukushima K; Yoneoka D; Suzuki M; Kamigaki T
Lancet Reg Health West Pac; 2023 Dec; 41():100911. PubMed ID: 38223396
[TBL] [Abstract][Full Text] [Related]
34. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
Pedersen RM; Bang LL; Madsen LW; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE
Emerg Infect Dis; 2022 Jun; 28(6):1274-1275. PubMed ID: 35356875
[TBL] [Abstract][Full Text] [Related]
35. An Early and Preliminary Assessment of the Clinical Severity of the Emerging SARS-CoV-2 Omicron Variants in Maharashtra, India.
Karyakarte RP; Das R; Taji N; Yanamandra S; Shende S; Joshi S; Karekar B; Bawale R; Tiwari R; Jadhav M; Sakalkar S; Chaudhari G; Rane S; Agarasen J; Pillai P; Dudhate S; Chandankhede P; Labhshetwar R; Gadiyal Y; Rajmane M; Mukade S; Kulkarni P
Cureus; 2022 Nov; 14(11):e31352. PubMed ID: 36514661
[TBL] [Abstract][Full Text] [Related]
36. Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.
Basheer A; Zahoor I; Yaqub T
PLoS One; 2023; 18(5):e0281159. PubMed ID: 37224159
[TBL] [Abstract][Full Text] [Related]
37. Tracking the first SARS-CoV-2 Omicron BA.5.1.3 outbreak in China.
Wang X; Zhu X; Lin Y; He L; Yang J; Wang C; Zhu W
Front Microbiol; 2023; 14():1183633. PubMed ID: 37275159
[TBL] [Abstract][Full Text] [Related]
38. Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020-March 2021).
Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Accogli M; Fortunato F; Parisi A; Chironna M
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33947087
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Clinical Outcomes and Imaging Features in Hospitalized Patients with SARS-CoV-2 Omicron Subvariants.
Lee JE; Hwang M; Kim YH; Chung MJ; Jeong WG; Sim BH; Jeong YJ
Radiology; 2023 Jul; 308(1):e230653. PubMed ID: 37462497
[TBL] [Abstract][Full Text] [Related]
40. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
